Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CardieX ( (AU:CDX) ) has shared an announcement.
Cardiex Limited held an Extraordinary General Meeting where all proposed resolutions were successfully passed by poll. The resolutions included the ratification of prior issues of placement shares and options, approval of participation in placements, and long-term incentives for directors and employees, indicating strong shareholder support and strategic alignment with the company’s growth plans.
More about CardieX
Cardiex is a company focused on advancing medical technology for vascular health. Their products include medical and home health devices, as well as digital solutions for hypertension, cardiovascular disease, and other vascular health disorders, utilizing their SphygmoCor® vascular biomarker technology. Cardiex is listed on the Australian Stock Exchange under the ticker ASX:CDX.
Average Trading Volume: 242,307
Technical Sentiment Signal: Sell
Current Market Cap: A$23.5M
For an in-depth examination of CDX stock, go to TipRanks’ Stock Analysis page.